Hands-On Learning Labs
Halls C & D
ACC.11 and i2 Summit attendees will have the opportunity to gain hands-on training in the Hands-On Learning Labs. Located in Expo Halls C & D, the Hands-On Learning Labs combine a presentation by a clinical or technical expert on a specific topic with a tutorial that leads you through procedures with a particular device, piece of equipment or workstation. This is an unparalleled opportunity to experience a dynamic learning environment during the ACC Annual Scientific Session & Expo.
Hands-On Learning Labs are hosted by:
Presentation schedules are current as of Feb. 4, 2011, and are subject to change. Please check the ACC.11 ExpoGuide and ExpoGuide Addendum, available at the Expo Hall entrances and in your Official Meeting Bag, for more updated information.
Connection PAH
A dynamic meeting of the minds at ACC.11, including an interactive discussion with key pulmonary arterial hypertension (PAH) opinion leaders and an exploration of current topics in PAH pertinent to the cardiologist, featuring presentations and Q&As in a small group setting.
Sunday, April 3 | 9:30 a.m.–11:30 a.m. (Breakfast provided 9:30 a.m.–10:00 a.m.)
Critical Issues in Pulmonary Arterial Hypertension (PAH): An Interactive Program for Fellows
Richard N. Channick, MD, FCCP—Director, Pulmonary Hypertension Program, Massachusetts General Hospital; Editor-in-Chief, Advances in Pulmonary Hypertension; Boston, MA
Vallerie V. McLaughlin, MD, FACC, FCCP, FAHA—Professor of Medicine, Department of Internal Medicine; Director, Pulmonary Hypertension Program, University of Michigan Cardiovascular Center; Ann Arbor, MI
Space is limited. Preregistration is required. Please visit www.fellowsprogramreg.com.
Sunday, April 3 | 12:30 p.m. - 2:30 p.m. (lunch provided 12:30 p.m.–1:00 p.m.)
Critical Issues in Pulmonary Arterial Hypertension (PAH): An Interactive Program for Fellows
Richard N. Channick, MD, FCCP—Director, Pulmonary Hypertension Program, Massachusetts General Hospital; Editor-in-Chief, Advances in Pulmonary Hypertension; Boston, MA
Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP—Professor of Medicine, Department of Internal Medicine; Director, Pulmonary Hypertension Program, University of Michigan Cardiovascular Center; Ann Arbor, MI
Space is limited. Preregistration is required. Please visit www.fellowsprogramreg.com.
Monday, April 4 | 12:00 p.m.–2:00 p.m. (lunch provided 12:00 p.m.–12:30 p.m.)
PAH: Who What When
Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP— Director, Pulmonary Hypertension Program, Professor of Medicine, Department of Internal Medicine, University of Michigan Health System; Ann Arbor, MI
Richard N. Channick, MD, FCCP—Director, Pulmonary Hypertension Program, Massachusetts General Hospital; Editor-in-Chief, Advances in Pulmonary Hypertension; Boston, MA
Wayne J. Franklin, MD—Medical Director, Texas Adult Congenital Heart Disease Center, Assistant Professor of Medicine, Baylor College of Medicine; Houston, TX
An interactive discussion with key PAH opinion leaders, moderated by Vallerie McLaughlin, MD.
Areas of Exploration:
- Uncovering PAH in an at-risk patient population
- Inhaled PAH therapy: a clinical review, issues and answers
- I.V. therapy in PAH: clinical challenges and potential therapeutic opportunities for the cardiologist
Space is limited. Preregistration is required. Visit www.connectionpah.com to register.
Monday, April 4 | 3:00 p.m.–4:45 p.m.
Meet the Experts: A Dynamic Meeting of the Minds
Peter J. Engel, MD, FACC—Medical Director, Pulmonary Hypertension Program, Ohio Heart & Vascular Center, The Christ Hospital; Cincinnati, OH
Richard N. Channick, MD, FCCP—Director, Pulmonary Hypertension Program, Massachusetts General Hospital; Editor-in-Chief, Advances in Pulmonary Hypertension; Boston, MA
Wayne J. Franklin, MD—Medical Director, Texas Adult Congenital Heart Disease Center, Assistant Professor of Medicine, Baylor College of Medicine; Houston, TX
Explore current topics in pulmonary arterial hypertension pertinent to the cardiologist, featuring presentations and Q&As by leading PAH experts in a small group setting.
Areas of Exploration:
- The value of monitoring patient compliance to support patient management in the treatment of PAH
- PAH in adults with congenital systemic-to-pulmonary shunts: identification and treatment
- Optimizing I.V. therapy in PAH functional class IV patients
Space is limited. Admission is on a first-come, first-served basis. Refreshments will be served.
Tuesday, April 5 | 9:00 a.m.–11: 00 a.m. (breakfast provided 9:00 a.m.–9:30 a.m.)
PAH: Who What When
Vallerie V. McLaughlin, MD, FACC, FAHA, FCCP— Director, Pulmonary Hypertension Program, Professor of Medicine, Department of Internal Medicine, University of Michigan Health System; Ann Arbor, MI
Wayne J. Franklin, MD—Medical Director, Texas Adult Congenital Heart Disease Center, Assistant Professor of Medicine, Baylor College of Medicine; Houston, TX
Sean M. Studer, MD, MSc, FCCP—Chief, Pulmonary and Critical Care; Director, Lung Transplant, Pulmonary Hypertension & Advanced Lung Disease, Newark Beth Israel Medical Center; Newark, NJ
An interactive discussion with key PAH opinion leaders, moderated by Vallerie McLaughlin, MD.
Areas of Exploration:
- Uncovering PAH in an at-risk patient population
- Inhaled PAH therapy: a clinical review, issues and answers
- I.V. therapy in PAH: clinical challenges and potential therapeutic opportunities for the cardiologist
Space is limited. Preregistration is required. Visit www.connectionpah.com to register.
Tuesday, April 5 | 12:00 p.m.–1:30 p.m.
Meet the Experts: A Dynamic Meeting of the Minds
Peter J. Engel, MD, FACC—Medical Director, Pulmonary Hypertension Program, Ohio Heart & Vascular Center, The Christ Hospital; Cincinnati, OH
Sean M. Studer, MD, MSc, FCCP—Chief, Pulmonary and Critical Care; Director, Lung Transplant, Pulmonary Hypertension & Advanced Lung Disease, Newark Beth Israel Medical Center; Newark, NJ
Wayne J. Franklin, MD—Medical Director, Texas Adult Congenital Heart Disease Center, Assistant Professor of Medicine, Baylor College of Medicine; Houston, TX
Explore current topics in pulmonary arterial hypertension pertinent to the cardiologist, featuring presentations and Q&As by leading PAH experts in a small group setting.
Areas of Exploration:
- The value of monitoring patient compliance to support patient management in the treatment of PAH
- PAH in adults with congenital systemic-to-pulmonary shunts: identification and treatment
- Optimizing I.V. therapy in PAH functional class IV patients
Space is limited. Admission is on a first-come, first-served basis. Refreshments will be served.
Return to top
Philips
Hands-On Learning Lab #3009
Please visit the Philips Healthcare Web site to register for these presentations. Space is limited, so please sign up today.
Sunday, April 3 | 9:30 a.m.–10:30 a.m.
Practical Aspects of Managing a Sleep Disordered Breathing Patient with Cardiovascular Disease
Lee A. Surkin, MD, FACC, FASNC, FCCP—Cardiology Wellness Specialists; Williamston, SC
This session will focus on the growing recognition and management of patients with cardiovascular disease and sleep disordered breathing. The physician will focus on identification and management techniques for patients with cardiovascular disease and co-existing sleep disordered breathing.
Sunday, April 3 | 11:00 a.m.–12:00 p.m.
Speckle Tracking: From Cardiac Mechanics to Outcome
Ivan S. Salgo, MD, MS—Chief, Cardiovascular Investigations, Philips Ultrasound
This presentation will provide an overview of the basis for speckle tracking: from cardiac mechanics, to ultrasound acoustics and patient outcomes. Dr. Salgo will outline how strain is used to assess and stratify patients with impaired function, along with optimal practices for using Philips’s Cardiac Motion Quantification technology.
Sunday, April 3 | 12:30 p.m.–1:30 p.m.
Integrating 3D Ultrasound in the Cath Lab for Structural Heart Disease Repair—Today and Tomorrow
John D. Carroll, MD—Professor of Medicine, University of Colorado; Denver, CO; Director, Interventional Cardiology; Medical Director, Cardiac and Vascular Center; University of Colorado Hospital
Dr. Carroll discusses how to integrate echocardiography into the cardiac cath lab or hybrid cardiac OR to optimize safety and efficiency of structural heart disease (SHD) interventions. Dr. Carroll demonstrates how their team has integrated not only imaging modalities but also the noninvasive imaging team for very effective structural heart disease interventions—with images and clips from closure of larger atrial septal defects (ASD) and other advanced SHD repairs. Includes indications for use for 2D ICE and real-time 3D TEE today, and trends for the future.
Sunday, April 3 | 2:15 p.m.–3:15 p.m.
Tips and Techniques to Reduce Dose, and Artifacts and Accuracy on Your Cardiac CT
Milind Y. Desai, MD—Director, Cardiac CT and MRI, Heart and Vascular Institute; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Foundation; Cleveland, OH
Tips and Techniques to Reduce Dose—Have you struggled with maintaining image quality while lowering radiation dose? Learn tips and techniques on how to reduce radiation dose in cardiac CT while maintaining optimal image quality.
Artifacts and Accuracy on Your Cardiac CT—Artifacts in cardiac CT can potentially hamper your diagnostic accuracy. This session focuses on what you should be aware of when imaging with artifacts, how you can reduce interference and be confident in your diagnosis.
Sunday, April 3 | 3:45 p.m.–4:45 p.m.
Hypothermia for Cardiac Protection in Acute Myocardial Infarction
David Erlinge, MD, PhD, FESC—Head, Department of Cardiology; Lund University Hospital; Sweden
This presentation will provide an overview of the development of endovascular therapeutic hypothermia to reduce infarct size in conscious patients with anterior and large inferior STEMI including pre-clinical and clinical data. The effect of therapeutic hypothermia on cardiogenic shock and reactive hyperemia, as well as emerging clinical trials and protocols will be discussed.
Monday, April 4 | 9:30 a.m.–10:30 a.m.
Management Tips for the Heart Failure Patient with Sleep Disordered Breathing
Darshak Karia, MD, FACC—Section Chief, Heart Failure Medical Director, Mechanical Circulatory Support Program, Einstein Heart and Vascular Institute, Albert Einstein Medical Center; Philadelphia, PA
William T. Abraham, MD, FACC, FACP, FAHA, FESC—Professor of Internal Medicine, Cell Biology, and Physiology; Chair of Excellence in Cardiovascular Medicine; Director, Division of Cardiovascular Medicine, The Ohio State University; Columbus, OH
This session will focus on the growing recognition and management of patients with heart failure and sleep disordered breathing. The physicians will focus on their management techniques for patients with acute and chronic heart failure who also have co-existing sleep disordered breathing.
Monday, April 4 | 11:00 a.m.–12:00 p.m.
Tips and Techniques to Reduce Dose, and Artifacts and Accuracy on Your Cardiac CT
Milind Y. Desai, MD—Director, Cardiac CT and MRI, Heart and Vascular Institute; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine, Cleveland Clinic Foundation; Cleveland, OH
Tips and Techniques to Reduce Dose—Have you struggled with maintaining image quality while lowering radiation dose? Learn tips and techniques on how to reduce radiation dose in cardiac CT while maintaining optimal image quality.
Artifacts and Accuracy on Your Cardiac CT—Artifacts in cardiac CT can potentially hamper your diagnostic accuracy. This session focuses on what you should be aware of when imaging with artifacts, how you can reduce interference and be confident in your diagnosis.
Monday, April 4 | 12:30 p.m.–1:30 p.m.
Integrating 3D Ultrasound in the Cath Lab for Structural Heart Disease Repair—Today and Tomorrow
John D. Carroll, MD—Professor of Medicine, University of Colorado; Denver, CO; Director, Interventional Cardiology; Medical Director, Cardiac and Vascular Center; University of Colorado Hospital
Dr. Carroll discusses how to integrate echocardiography into the cardiac cath lab or hybrid cardiac OR to optimize safety and eficiency of structural heart disease (SHD) interventions. Dr. Carroll demonstrates how their team has integrated not only imaging modalities but also the noninvasive imaging team for very effective structural heart disease interventions—with images and clips from closure of larger atrial septal defects (ASD) and other advanced SHD repairs. Includes indications for use for 2D ICE and real-time 3D TEE today, and trends for the future.
Monday, April 4 | 2:15 p.m.–3:15 p.m.
Speckle Tracking: From Cardiac Mechanics to Outcome
Ivan S. Salgo, MD, MS—Chief, Cardiovascular Investigations, Philips Ultrasound
This presentation will provide an overview of the basis for speckle tracking: from cardiac mechanics, to ultrasound acoustics and patient outcomes. Dr. Salgo will outline how strain is used to assess and stratify patients with impaired function, along with optimal practices for using Philips’s Cardiac Motion Quantification technology.
Monday, April 4 | 3:45–4:45 p.m.
Hypothermia for Cardiac Protection in Acute Myocardial Infarction
David Erlinge, MD, PhD, FESC—Head, Department of Cardiology; Lund University Hospital; Sweden
This presentation will provide an overview of the development of endovascular therapeutic hypothermia to reduce infarct size in conscious patients with anterior and large inferior STEMI including pre-clinical and clinical data. The effect of therapeutic hypothermia on cardiogenic shock and reactive hyperemia, as well as emerging clinical trials and protocols will be discussed.
Please visit the Philips Healthcare Web site to register for these presentations. Space is limited, so please sign up today.
Return to top
Transradial Access and Procedural Anticoagulation Therapies
Physicians will partake in didactic training, to include tips and tricks, equipment usage, pharmacology and complex cases. Participants will practice cases and learn access techniques with various transradial simulators. In addition, they will learn about hemostasis techniques along with procedural anticoagulation therapies.
Advance registration is advised. Sign up today, space is limited. Visit www.terumois.com/acc11lab.
Sunday, April 3 | 9:30 a.m.–11:00 a.m.
Tak Kwan, MD
Sunday, April 3 | 11:00 a.m.–12:30 p.m.
Branavan Umakanthan, MD
Sunday, April 3 | 1:30 p.m.–3:00 p.m.
Michael Liou, MD
Sunday, April 3 | 3:00 p.m.–4:30 p.m.
Tak Kwan, MD
Monday, April 4 | 9:30 a.m.–11:00 a.m.
Sunil Rao, MD
Monday, April 4 | 11:00 a.m.–12:30 p.m.
Michael Liou, MD
Monday, April 4 | 1:30 p.m.–3:00 p.m.
Mauricio Cohen, MD
Monday, April 4 | 3:00 p.m.–4:30 p.m.
Daniel Steinberg, MD
Tuesday, April 5 | 9:30 a.m.–11:00 a.m.
Sunil Rao, MD
Tuesday, April 5 | 11:00 a.m.–12:30 p.m.
Daniel Steinberg, MD
Please note that presentations in the Hands-On Learning Labs do not qualify for continuing medical education (CME/CNE/CE) credit.
Please note: Hands-On Learning Lab presentations are not part of the official ACC Annual Scientific Session and/or the American College of Cardiology’s Innovation in Intervention: i2 Summit in Partnership with the Cardiovascular Research Foundation (CRF) as planned by their Program Committees.